Abstract:Cancer classification plays an important role in cancer treatment. There has been no general approach for this problem now. The tasks for cancer classification are of two aspects: identifying new cancer classes and assigning tumors to known classes, which are called class discovery and class prediction by Golub et al. [1]. From mathematical point of view, class discovery is a cluster analysis problem, while class prediction is usually called classification problem (we’ll use the later name to keep consist with pattern recognition literatures). Until now, cancer classification has been based primarily on morphological appearance of tumor [1]. This has serious limitations because of ambiguity. Golub et al. presented a new approach to cancer classification based on gene expression monitoring by DNA microarrays in [1]. They chose acute leukemia as a test case, and the target is to distinguish between ALL (acute lymphoblastic leukemia) and AML (acute myeloid leukemia), which is a typical cancer classification problem not well solved despite many years of efforts. This paper is a report of our work on the classification (prediction) part of this problem following their original work. Golub et al. adopted a feature selection (gene selection) procedure before classification. A metric was defined to evaluate the correlation of each gene to the classification. After some “good” genes were selected from all the 6817 genes, the classification is done by a weighted voting scheme. The classifier was trained on a 38-sample training set, and another 34-sample set was used for testing. With leave-one-out cross-validation on the training set with 50 selected genes, 36 out of 38 samples were correctly classified and 2 were rejected (no-call). The performance on the test set was that 29 samples out of 34 were correctly classified and the other 5 were rejected. If the classifier were compelled to give these 5 no-calls a prediction, the prediction would be wrong. Since the feature selection procedure is of single selection type, and the classification method is also an intuitive one, we believe that there is still much space for the performance to be improved. In our approach to the problem, we took all the genes for the classification (the selection problem will be discussed in another paper), and applied the support vector machine(SVM) method and one of its improved version CSVM as the classifier. Thanks to the better generalization ability of SVM and CSVM, much better performance was obtained.

Cancer classification from the gene expression profiles by Discriminant Kernel-PLS.

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile

Biological Pathway Conducting Microarray-Based Cancer Classification

PLS-Based Gene Selection and Identification of Tumor-Specific Genes

Several Cancer Classifiers Combined with PLS- DR for Base on Gene Expression Profile

Computational Analysis of Leukemia Microarray Expression Data Using the GA/KNN Method

Two Multiple Classification Methods Based on Partial Least Squares Using Tumor Microarray Gene Expression Data on a Comparative Study

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

RPCA-Based Tumor Classification Using Gene Expression Data

Cancer Subtype Recognition and Feature Selection with Gene Expression Profiles

Classifying Dna Microarray For Cancer Diagnosis Via Method Based On Complex Networks

Several New Tools for Cancer Classification Combined with PLSDR Base on High-Dimensional Gene Expression Profile

Cancer classification based on microarray gene expression data using a principal component accumulation method

A Novel Method for Gene Selection and Cancer Classification

On Gene Selection and Classification for Cancer Microarray Data Using Multi-Step Clustering and Sparse Representation

Gene Expression Data Classification with Revised Kernel Partial Least Squares Algorithm

Generalized Discriminant Analysis for Tumor Classification with Gene Expression Data

[Research on pattern classification methods using gene expression data].

ALL/AML Cancer Classification by Gene Expression Data Using SVM and CSVM Approach

Feature Extraction For Cancer Classification Using Kernel-Based Methods

Independent Component Analysis-Based Penalized Discriminant Method for Tumor Classification Using Gene Expression Data.